Emergent Biosolutions
EBS
EBS
275 hedge funds and large institutions have $2.79B invested in Emergent Biosolutions in 2018 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 91 increasing their positions, 106 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
275
Holders Change
+12
Holders Change %
+4.56%
% of All Funds
6.3%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
39
Increased
91
Reduced
106
Closed
25
Calls
$3.22M
Puts
$2.22M
Net Calls
+$1M
Net Calls Change
+$1.14M
Top Buyers
| 1 |
BlackRock
New York
|
$418M |
| 2 |
Neuberger Berman Group
New York
|
$22.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
$74.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$303M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
$22.2M |
